Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EV/Core EBITDA

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 44.7216.898.4210.5617.37

What is the latest EV/Core EBITDA ratio of NEULAND LABORATORIES ?

The latest EV/Core EBITDA ratio of NEULAND LABORATORIES is 44.72 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202544.72
Mar202416.89
Mar20238.42
Mar202210.56
Mar202117.37

How is EV/Core EBITDA of NEULAND LABORATORIES Trending?

Years EV/Core EBITDA % Change
Mar2025 44.72
164.77
Mar2024 16.89
100.59
Mar2023 8.42
-20.27
Mar2022 10.56
-39.21
Mar2021 17.37 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EV/Core EBITDA ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,797.8 Cr 0.8% 17.1% 64.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.5% 4.1% -0.8% Stock Analytics
DIVIS LABORATORIES ₹176,604.0 Cr 0.5% -2.9% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,316.0 Cr 6.2% 9.3% 17.9% Stock Analytics
CIPLA ₹125,993.0 Cr 4.9% 2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,795.0 Cr 2.1% 1.2% -5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

0.8%

17.1%

64.7%

SENSEX

-1.5%

-2.5%

0.2%


You may also like the below Video Courses